Question

A scientist wrote an article about a drug that he believes reduces the effects of viral infections. Which of these MOST LIKELY needs to be done by a scientific committee before the drug is made available to the general public?

Answer 1

They would require rigorous, independent clinical testing and regulatory review to establish safety and efficacy — i.e., well‑designed trials (Phase I–III, usually randomized double‑blind placebo‑controlled), ethical/IRB approval, independent replication and peer review, and formal approval by the relevant regulatory agency (e.g., FDA) before public release.